Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 223 articles:
HTML format



Single Articles


    November 2021
  1. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    PubMed     Abstract available


  2. POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
    Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
    Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
    PubMed     Abstract available


  3. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    PubMed     Abstract available


  4. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    PubMed     Abstract available


  5. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    PubMed     Abstract available


  6. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    PubMed     Abstract available


  7. BRAMUGY J, Mucasse H, Massora S, Vitorino P, et al
    Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction.
    Clin Infect Dis. 2021 Nov 2. pii: 6388780. doi: 10.1093.
    PubMed     Abstract available


  8. MALVOLTI S, Pecenka C, Mantel C, Malhame M, et al
    A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women.
    Clin Infect Dis. 2021 Nov 2. pii: 6412619. doi: 10.1093.
    PubMed     Abstract available


  9. BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
    Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
    Clin Infect Dis. 2021;73:1617-1624.
    PubMed     Abstract available


  10. BERENSON AB, Hirth JM, Chang M
    Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Clin Infect Dis. 2021;73:1625-1633.
    PubMed     Abstract available


  11. MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
    Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
    Clin Infect Dis. 2021;73:e2680-e2689.
    PubMed     Abstract available


  12. THOMPSON RR, Kong CL, Porco TC, Kim E, et al
    Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
    Clin Infect Dis. 2021;73:e3210-e3217.
    PubMed     Abstract available


  13. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Clin Infect Dis. 2021;73:e2538-e2544.
    PubMed     Abstract available


  14. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
    Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
    Clin Infect Dis. 2021;73:e2502-e2508.
    PubMed     Abstract available


  15. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2021;73:e3308-e3316.
    PubMed     Abstract available


    October 2021
  16. MARSHALL GS, Ghaswalla PK, Bengtson LGS, Buikema AR, et al
    Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
    Clin Infect Dis. 2021 Oct 28. pii: 6413775. doi: 10.1093.
    PubMed     Abstract available


  17. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    PubMed     Abstract available


  18. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.
    PubMed    


  19. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    PubMed     Abstract available


  20. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    PubMed     Abstract available


  21. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    PubMed     Abstract available


  22. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    PubMed     Abstract available


  23. ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
    Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Clin Infect Dis. 2021;73:1216-1222.
    PubMed     Abstract available


  24. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
    Clin Infect Dis. 2021;73:e1661-e1668.
    PubMed     Abstract available


  25. MARSHALL HS, Maiden MCJ
    Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
    Clin Infect Dis. 2021;73:e1669-e1672.
    PubMed    


  26. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed     Abstract available


  27. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2021;73:e1546-e1553.
    PubMed     Abstract available


  28. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2021;73:e1489-e1497.
    PubMed     Abstract available


  29. RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
    Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
    Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  30. MANTEL C, Cherian T, Ko M, Malvoti S, et al
    Stakeholder perceptions about Group B Streptococcus disease and potential for maternal vaccination in low and middle-income countries.
    Clin Infect Dis. 2021 Sep 24. pii: 6374850. doi: 10.1093.
    PubMed     Abstract available


  31. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    PubMed     Abstract available


  32. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    PubMed     Abstract available


  33. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    PubMed     Abstract available


  34. OHM M, Hahne SJM, van der Ende A, Sanders EAM, et al
    Vaccine impact and effectiveness of meningococcal serogroup ACWY conjugate vaccine implementation in the Netherlands: a nationwide surveillance study.
    Clin Infect Dis. 2021 Sep 15. pii: 6370762. doi: 10.1093.
    PubMed     Abstract available


  35. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    PubMed     Abstract available


  36. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
    Clin Infect Dis. 2021;73:935-936.
    PubMed    


  37. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    PubMed     Abstract available


  38. MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
    Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  39. SRIKANTIAH P, Vora P, Klugman KP
    Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  40. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  41. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    PubMed     Abstract available


  42. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    PubMed    


  43. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    PubMed     Abstract available


  44. YILDIRIM I, Kao CM, Tippett A, Suntarattiwong P, et al
    A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.
    Clin Infect Dis. 2021 Aug 19. pii: 6354891. doi: 10.1093.
    PubMed     Abstract available


  45. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    PubMed     Abstract available


  46. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    PubMed    


  47. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    PubMed     Abstract available


  48. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    PubMed     Abstract available


  49. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    PubMed    


    July 2021
  50. GHAMANDE S, Shaver C, Murthy K, Raiyani C, et al
    Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Clin Infect Dis. 2021 Jul 28. pii: 6329674. doi: 10.1093.
    PubMed     Abstract available


  51. BOLLAERTS K, Fletcher MA, Suaya JA, Hanquet G, et al
    Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.
    Clin Infect Dis. 2021 Jul 27. pii: 6329127. doi: 10.1093.
    PubMed     Abstract available


  52. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    PubMed     Abstract available


  53. NAUCLER P, Galanis I, Petropoulos A, Granath F, et al
    Chronic disease and immunosuppression increase the risk for non-vaccine serotype pneumococcal disease - a nationwide population-based study.
    Clin Infect Dis. 2021 Jul 24. pii: 6327794. doi: 10.1093.
    PubMed     Abstract available


  54. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    PubMed     Abstract available


  55. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    PubMed     Abstract available


  56. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    PubMed     Abstract available


  57. BOUTRY C, Hastie A, Diez-Domingo J, Tinoco JC, et al
    The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).
    Clin Infect Dis. 2021 Jul 20. pii: 6324611. doi: 10.1093.
    PubMed     Abstract available


  58. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    PubMed     Abstract available


  59. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    PubMed     Abstract available


  60. TOTA JE, Giuliano AR, Goldstone SE, Dubin B, et al
    Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2021 Jul 15. pii: 6321740. doi: 10.1093.
    PubMed     Abstract available


  61. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    PubMed     Abstract available


  62. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    PubMed     Abstract available


  63. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    PubMed     Abstract available


  64. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    PubMed     Abstract available


  65. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    PubMed     Abstract available


  66. BERENSON AB, Hirth JM, Chang M
    Prevalence of oral human papillomavirus infection: Impact of sex, race/ethnicity and vaccination status.
    Clin Infect Dis. 2021 Jul 4. pii: 6314534. doi: 10.1093.
    PubMed     Abstract available


  67. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  68. ANDREJKO K, Whittles LK, Lewnard JA
    Health-economic value of vaccination against group A Streptococcus in the United States.
    Clin Infect Dis. 2021 Jun 30. pii: 6311854. doi: 10.1093.
    PubMed     Abstract available


  69. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    PubMed     Abstract available


  70. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    PubMed     Abstract available


  71. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    PubMed    


  72. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    PubMed     Abstract available


  73. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    PubMed     Abstract available


  74. METCALF BJ, Chochua S, Walker H, Tran T, et al
    Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
    Clin Infect Dis. 2021;72:e948-e956.
    PubMed     Abstract available


  75. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    PubMed     Abstract available


  76. CURREN EJ, Shankar MB, Fischer M, Meltzer MI, et al
    Cost effectiveness and impact of a targeted age- and incidence-based West Nile virus vaccine strategy.
    Clin Infect Dis. 2021 Jun 12. pii: 6297173. doi: 10.1093.
    PubMed     Abstract available


  77. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    PubMed    


  78. MWENDA JM, Hallowell BD, Parashar U, Shaba K, et al
    Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018.
    Clin Infect Dis. 2021 Jun 5. pii: 6293961. doi: 10.1093.
    PubMed     Abstract available


  79. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    PubMed     Abstract available


  80. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    PubMed     Abstract available


  81. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    PubMed    


  82. WYLLIE AL, Warren JL, Regev-Yochay G, Givon-Lavi N, et al
    Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children.
    Clin Infect Dis. 2021;72:e768-e775.
    PubMed     Abstract available


  83. AFRICANO HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, Bustos IG, et al
    Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.
    Clin Infect Dis. 2021;72:e711-e719.
    PubMed     Abstract available


    May 2021
  84. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    PubMed     Abstract available


  85. GOWER CM, Stowe J, Andrews NJ, Dunning J, et al
    Sustained declines in age group-specific rotavirus infection and acute gastroenteritis in vaccinated and unvaccinated individuals during the five years since Rotavirus vaccine introduction in England.
    Clin Infect Dis. 2021 May 27. pii: 6287118. doi: 10.1093.
    PubMed     Abstract available


  86. NEWALL AT, Leong RN, Reyes JF, Curns AT, et al
    Rotavirus vaccination likely to be cost saving to society in the United States.
    Clin Infect Dis. 2021 May 26. pii: 6285405. doi: 10.1093.
    PubMed     Abstract available


  87. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    PubMed    


  88. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    PubMed     Abstract available


  89. GRIJALVA CG, Feldstein LR, Talbot HK, Aboodi M, et al
    Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.
    Clin Infect Dis. 2021 May 20. pii: 6279050. doi: 10.1093.
    PubMed     Abstract available


  90. DANINO D, Van Der Beek BA, Givon-Lavi N, Greenberg D, et al
    Unravelling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2021 May 20. pii: 6278471. doi: 10.1093.
    PubMed     Abstract available


  91. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
    PubMed    


  92. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    PubMed     Abstract available


  93. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    PubMed     Abstract available


  94. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    PubMed     Abstract available


  95. PALEFSKY JM, Lensing SY, Belzer M, Lee J, et al
    High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with HIV.
    Clin Infect Dis. 2021 May 15. pii: 6276233. doi: 10.1093.
    PubMed     Abstract available


  96. VANIJCHAROENKARN K, Lee FE, Martin L, Shih J, et al
    Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.
    Clin Infect Dis. 2021 May 14. pii: 6275836. doi: 10.1093.
    PubMed     Abstract available


  97. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    PubMed     Abstract available


  98. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    PubMed     Abstract available


  99. YADAV PD, Sapkal GN, Abraham P, Ella R, et al
    Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees.
    Clin Infect Dis. 2021 May 7. pii: 6271524. doi: 10.1093.
    PubMed    


  100. MALOSH RE, Petrie JG, Callear A, Truscon R, et al
    Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection?
    Clin Infect Dis. 2021 May 5. pii: 6265275. doi: 10.1093.
    PubMed     Abstract available


  101. ORTIZ JR, Yu SL, Driscoll AJ, Williams SR, et al
    The operational feasibility of vaccination programs targeting influenza risk groups in the WHO African and South-East Asian Regions.
    Clin Infect Dis. 2021 May 5. pii: 6265274. doi: 10.1093.
    PubMed     Abstract available


  102. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    PubMed    


  103. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    PubMed    


  104. HAIDAR G, Mellors JW
    Improving the Outcomes of Immunocompromised Patients with COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265293. doi: 10.1093.
    PubMed     Abstract available


  105. BENET T, Amour S, Valette M, Saadatian-Elahi M, et al
    Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2021;72:e311-e318.
    PubMed     Abstract available


  106. SALAMA M, Indenbaum V, Nuss N, Savion M, et al
    A Measles Outbreak in the Tel Aviv District, Israel, 2018-2019.
    Clin Infect Dis. 2021;72:1649-1656.
    PubMed     Abstract available


    April 2021
  107. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    PubMed     Abstract available


  108. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    PubMed     Abstract available


  109. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    PubMed     Abstract available


  110. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    PubMed     Abstract available


  111. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    PubMed     Abstract available


  112. COHEN R, Levy C, Ouldali N, Goldrey M, et al
    Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation.
    Clin Infect Dis. 2021;72:1453-1456.
    PubMed     Abstract available


  113. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    PubMed     Abstract available


  114. RANE MS, Halloran ME
    Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data.
    Clin Infect Dis. 2021 Apr 21. pii: 6243988. doi: 10.1093.
    PubMed     Abstract available


  115. DAGAN R, Ben-Shimol S, Greenberg D, Givon-Lavi N, et al
    A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
    Clin Infect Dis. 2021;72:1200-1207.
    PubMed     Abstract available


  116. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    PubMed    


  117. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    PubMed    


  118. FORRAT R, Dayan GH, DiazGranados CA, Bonaparte M, et al
    Analysis of hospitalized and severe dengue cases over the six-years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America.
    Clin Infect Dis. 2021 Apr 4. pii: 6210060. doi: 10.1093.
    PubMed     Abstract available


  119. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  120. HALSTEAD SB
    Is Dengue Vaccine Protection Possible?
    Clin Infect Dis. 2021 Mar 31. pii: 6206739. doi: 10.1093.
    PubMed     Abstract available


  121. KISSLER SM, Mitchell M, Grad YH
    Reduction in antibiotic prescribing attainable with a gonococcal vaccine.
    Clin Infect Dis. 2021 Mar 31. pii: 6205093. doi: 10.1093.
    PubMed     Abstract available


  122. BODDINGTON NL, Pearson I, Whitaker H, Mangtani P, et al
    Effectiveness of influenza vaccination in preventing hospitalisation due to influenza in children: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Mar 27. pii: 6193428. doi: 10.1093.
    PubMed     Abstract available


  123. ORIJE MRP, Lariviere Y, Herzog SA, Mahieu LM, et al
    Breast milk antibody levels in Tdap vaccinated women after preterm delivery.
    Clin Infect Dis. 2021 Mar 26. pii: 6188768. doi: 10.1093.
    PubMed     Abstract available


  124. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    PubMed     Abstract available


  125. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    PubMed     Abstract available


  126. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    PubMed     Abstract available


  127. CZAJA CA, Cockburn MG, Colborn K, Miller L, et al
    Adult population coverage with influenza vaccine and influenza hospitalization rates-is there a role for active outreach to immunize at-risk neighborhoods?
    Clin Infect Dis. 2021 Mar 14. pii: 6170704. doi: 10.1093.
    PubMed     Abstract available


  128. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    PubMed     Abstract available


  129. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    PubMed     Abstract available


  130. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    PubMed    


  131. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  132. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    PubMed     Abstract available


  133. MEITES E, Stone L, Amiling R, Singh V, et al
    Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following HPV Vaccine Introduction in the United States.
    Clin Infect Dis. 2021 Feb 23. pii: 6148742. doi: 10.1093.
    PubMed     Abstract available


  134. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-Derived Quadrivalent Inactivated Influenza Vaccines and High-Dose Trivalent Influenza Vaccine in Preventing Influenza-Related Medical Encounters in US Adults >/=65
    Clin Infect Dis. 2021 Feb 19. pii: 6144977. doi: 10.1093.
    PubMed     Abstract available


  135. MCMILLAN M, Wang B, Koehler AP, Sullivan TR, et al
    Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.
    Clin Infect Dis. 2021 Feb 15. pii: 6136296. doi: 10.1093/cid/ciaa1636.
    PubMed     Abstract available


  136. SUN Y, Kim E, Kong CL, Arnold BF, et al
    Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study.
    Clin Infect Dis. 2021 Feb 13. pii: 6134288. doi: 10.1093.
    PubMed     Abstract available


  137. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    PubMed     Abstract available


  138. IZURIETA HS, Wu X, Forshee R, Lu Y, et al
    Recombinant Zoster Vaccine (Shingrix) real-world effectiveness in the first two years post-licensure.
    Clin Infect Dis. 2021 Feb 13. pii: 6134290. doi: 10.1093.
    PubMed     Abstract available


  139. HARPAZ R
    The Effectiveness of Recombinant Zoster Vaccine: Observations in the Wild.
    Clin Infect Dis. 2021 Feb 13. pii: 6134291. doi: 10.1093.
    PubMed    



  140. Corrigendum to: Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies.
    Clin Infect Dis. 2021 Feb 12. pii: 6134004. doi: 10.1093/cid/ciaa1767.
    PubMed    


  141. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    PubMed     Abstract available


  142. WOLTER N, Cohen C, Tempia S, Walaza S, et al
    Epidemiology of pertussis in individuals of all ages hospitalised with respiratory illness in South Africa, January 2013 - December 2018.
    Clin Infect Dis. 2021 Feb 2. pii: 6126768. doi: 10.1093.
    PubMed     Abstract available


  143. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    PubMed     Abstract available


  144. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    PubMed     Abstract available


  145. ANDERSEN MA, Niemann CU, Rostgaard K, Dalby T, et al
    Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.
    Clin Infect Dis. 2021;72:463-471.
    PubMed     Abstract available


    January 2021
  146. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    PubMed     Abstract available


  147. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    PubMed    


  148. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    PubMed    


  149. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    PubMed     Abstract available


  150. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost Efectiveness of Universal Varicella Vaccination with Different Varicella Vaccines in the UK.
    Clin Infect Dis. 2021 Jan 28. pii: 6122568. doi: 10.1093.
    PubMed    


  151. DAGAN R, van der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Effectiveness of the seven- and thirteen valent pneumococcal conjugate vaccines against vaccine-serotype otitis media.
    Clin Infect Dis. 2021 Jan 28. pii: 6122570. doi: 10.1093.
    PubMed     Abstract available


  152. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    PubMed    


  153. CAMPBELL AP, Ogokeh C, Weinberg GA, Boom JA, et al
    Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated with B/Victoria Viruses, 2019-2020.
    Clin Infect Dis. 2021 Jan 27. pii: 6121316. doi: 10.1093.
    PubMed     Abstract available


  154. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    PubMed    


  155. LONGLEY AT, Date K, Luby SP, Bhatnagar P, et al
    Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Clin Infect Dis. 2021 Jan 27. pii: 6121264. doi: 10.1093.
    PubMed     Abstract available


  156. MEISSNER HC, Plotkin SA
    The Facts About Vaccine Safety.
    Clin Infect Dis. 2021;72:309-310.
    PubMed     Abstract available


  157. MARTINS D, McCormack D, Tadrous M, Gomes T, et al
    Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study.
    Clin Infect Dis. 2021;72:279-284.
    PubMed     Abstract available


  158. VERHAGEN LM, Rivera-Olivero IA, Clerc M, Chu MLJN, et al
    Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections.
    Clin Infect Dis. 2021;72:212-221.
    PubMed     Abstract available


  159. VEKEMANS J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, et al
    Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework.
    Clin Infect Dis. 2021 Jan 25. pii: 6119610. doi: 10.1093.
    PubMed     Abstract available


  160. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    PubMed     Abstract available


  161. FERDINANDS JM, Gaglani M, Martin ET, Monto AS, et al
    Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    Clin Infect Dis. 2021 Jan 19. pii: 6104243. doi: 10.1093.
    PubMed     Abstract available


  162. LIPWORTH S, Vihta KD, Chau KK, Kavanagh J, et al
    Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections.
    Clin Infect Dis. 2021 Jan 7. pii: 6067638. doi: 10.1093.
    PubMed     Abstract available


  163. GRAVENSTEIN S, McConeghy KW, Saade E, Davidson HE, et al
    Adjuvanted influenza vaccine and influenza outbreaks in U.S. nursing homes: Results from a pragmatic cluster-randomized clinical trial.
    Clin Infect Dis. 2021 Jan 5. pii: 6064531. doi: 10.1093/cid/ciaa1916.
    PubMed     Abstract available


  164. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United
    Clin Infect Dis. 2021 Jan 5. pii: 6064642. doi: 10.1093/cid/ciaa1944.
    PubMed     Abstract available


  165. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    PubMed    


  166. HUGHES K, Middleton DB, Nowalk MP, Balasubramani GK, et al
    Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
    Clin Infect Dis. 2021 Jan 3. pii: 6060064. doi: 10.1093/cid/ciaa1927.
    PubMed     Abstract available


    December 2020
  167. BOEY L, Curinckx A, Roelants M, Derdelinckx I, et al
    Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults.
    Clin Infect Dis. 2020 Dec 29. pii: 6054974. doi: 10.1093/cid/ciaa1897.
    PubMed     Abstract available


  168. TENFORDE MW, Kondor RJG, Chung JR, Zimmerman RK, et al
    Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.
    Clin Infect Dis. 2020 Dec 25. pii: 6048924. doi: 10.1093/cid/ciaa1884.
    PubMed     Abstract available


  169. CHUNG H, Buchan SA, Campigotto A, Campitelli MA, et al
    Influenza vaccine effectiveness against all-cause mortality following laboratory-confirmed influenza in older adults, 2010-2011 to 2015-2016 seasons in Ontario, Canada.
    Clin Infect Dis. 2020 Dec 23. pii: 6044622. doi: 10.1093/cid/ciaa1862.
    PubMed     Abstract available


  170. LEWNARD JA, Givon-Lavi N, Dagan R
    Effectiveness of pneumococcal conjugate vaccines against community-acquired alveolar pneumonia attributable to vaccine-serotype Streptococcus pneumoniae among children.
    Clin Infect Dis. 2020 Dec 21. pii: 6042567. doi: 10.1093/cid/ciaa1860.
    PubMed     Abstract available


  171. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    PubMed     Abstract available


  172. LADHANI SN, Borrow R, Ramsay ME
    Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program.
    Clin Infect Dis. 2020 Dec 19. pii: 6042098. doi: 10.1093/cid/ciaa1644.
    PubMed    


  173. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    PubMed     Abstract available


  174. KLUGMAN KP, Rodgers GL
    Impact of pneumococcal conjugate vaccine on vaccine serotype specific pneumonia.
    Clin Infect Dis. 2020 Dec 18. pii: 6041689. doi: 10.1093/cid/ciaa1867.
    PubMed    


  175. CARTER AS, Luby SP, Garrett DO
    Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


    November 2020
  176. KOELMAN DLH, van Kassel MN, Bijlsma MW, Brouwer MC, et al
    Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: Three Decades of National Meningitis Surveillance in The Netherlands.
    Clin Infect Dis. 2020 Nov 28. pii: 6008501. doi: 10.1093/cid/ciaa1774.
    PubMed     Abstract available


  177. HOES J, Woestenberg PJ, Bogaards JA, King AJ, et al
    Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects.
    Clin Infect Dis. 2020 Nov 28. pii: 6010041. doi: 10.1093/cid/ciaa1770.
    PubMed     Abstract available


  178. MCMILLAN M, Chandrakumar A, Wang HLR, Clarke M, et al
    Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.
    Clin Infect Dis. 2020 Nov 19. pii: 5992465. doi: 10.1093/cid/ciaa1733.
    PubMed     Abstract available


  179. IZURIETA HS, Lu M, Kelman J, Lu Y, et al
    Comparative effectiveness of influenza vaccines among U.S. Medicare beneficiaries ages 65 years and older during the 2019-20 season.
    Clin Infect Dis. 2020 Nov 19. pii: 5992287. doi: 10.1093/cid/ciaa1727.
    PubMed     Abstract available


  180. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    PubMed    


  181. TEH BW, Leung VKY, Mordant FL, Sullivan SG, et al
    A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation.
    Clin Infect Dis. 2020 Nov 11. pii: 5974227. doi: 10.1093/cid/ciaa1711.
    PubMed     Abstract available


  182. AKPO EIH, Cristeau O, Hunjan M, Casabona G, et al
    Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom (UK).
    Clin Infect Dis. 2020 Nov 11. pii: 5973941. doi: 10.1093/cid/ciaa1708.
    PubMed     Abstract available


  183. NIANG MN, Sugimoto JD, Diallo A, Diarra B, et al
    Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011.
    Clin Infect Dis. 2020 Nov 9. pii: 5963906. doi: 10.1093/cid/ciaa1689.
    PubMed     Abstract available


  184. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    PubMed     Abstract available


  185. PELTON SI, Lapidot R
    Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network.
    Clin Infect Dis. 2020 Nov 5. pii: 5957066. doi: 10.1093/cid/ciaa1688.
    PubMed    


  186. SHINDE V, Cai R, Plested J, Cho I, et al
    Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
    Clin Infect Dis. 2020 Nov 4. pii: 5955953. doi: 10.1093/cid/ciaa1673.
    PubMed     Abstract available


    October 2020
  187. ESAULENKO EV, Yakovlev AA, Volkov GA, Sukhoruk AA, et al
    Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 randomized clinical trial in the Russian Federation.
    Clin Infect Dis. 2020 Oct 29. pii: 5942941. doi: 10.1093/cid/ciaa1649.
    PubMed     Abstract available


  188. UJIIE M
    Trends in the incidence of reported adverse events after changing the Bacillus Calmette-Guerin vaccination age in Japan.
    Clin Infect Dis. 2020 Oct 28. pii: 5942531. doi: 10.1093/cid/ciaa1640.
    PubMed    


  189. BAANDRUP L, Dehlendorff C, Kjaer SK
    One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
    Clin Infect Dis. 2020 Oct 13. pii: 5922377. doi: 10.1093/cid/ciaa1067.
    PubMed     Abstract available


  190. PAVLINAC PB, Platts-Mills JA, Tickell KD, Liu J, et al
    The clinical presentation of culture-positive and culture-negative, qPCR-attributable shigellosis in the Global Enteric Multicenter Study and derivation of a Shigella severity score: implications for pediatric Shigella vaccine trials.
    Clin Infect Dis. 2020 Oct 12. pii: 5921054. doi: 10.1093/cid/ciaa1545.
    PubMed     Abstract available


    September 2020
  191. XIE H, Xiang R, Wan HJ, Plant EP, et al
    Reduced Influenza B-specific Post-Vaccination Antibody Cross-reactivity in the B/Victoria Lineage Predominant 2019/20 Season.
    Clin Infect Dis. 2020 Sep 29. pii: 5912827. doi: 10.1093/cid/ciaa1481.
    PubMed     Abstract available


  192. BARDENHEIER BH, Baier RR, Silva JB, Gravenstein S, et al
    Persistence of Racial Inequities in Receipt of Influenza Vaccination among Nursing Home Residents in the United States.
    Clin Infect Dis. 2020 Sep 29. pii: 5912795. doi: 10.1093/cid/ciaa1484.
    PubMed     Abstract available


  193. DE MIGUEL S, Domenech M, Gonzalez-Camacho F, Sempere J, et al
    Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era.
    Clin Infect Dis. 2020 Sep 29. pii: 5912816. doi: 10.1093/cid/ciaa1483.
    PubMed     Abstract available


  194. FIRNHABER C, Swarts A, Jezile V, Mulongo M, et al
    HPV Vaccination Prior to Loop Electroexcision Procedure does not Prevent Recurrent Cervical High Grade Squamous Intraepithelial Lesions in Women Living with HIV: a Randomized, Double-blind, Placebo-controlled Trial.
    Clin Infect Dis. 2020 Sep 25. pii: 5911567. doi: 10.1093/cid/ciaa1456.
    PubMed     Abstract available


  195. FELDSTEIN LR, Self WH, Ferdinands JM, Randolph AG, et al
    Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND).
    Clin Infect Dis. 2020 Sep 25. pii: 5911459. doi: 10.1093/cid/ciaa1453.
    PubMed     Abstract available


  196. PLUMB ID, Gounder PP, Nolen LD, Massay SC, et al
    Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018.
    Clin Infect Dis. 2020 Sep 24. pii: 5910738. doi: 10.1093/cid/ciaa1102.
    PubMed     Abstract available


  197. ANDERSEN A, Fisker AB, Nielsen S, Rodrigues A, et al
    National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area.
    Clin Infect Dis. 2020 Sep 19. pii: 5909021. doi: 10.1093/cid/ciaa1351.
    PubMed     Abstract available


  198. ANDERSON EJ, Campbell JD, Creech CB, Frenck R, et al
    Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
    Clin Infect Dis. 2020 Sep 18. pii: 5908283. doi: 10.1093/cid/ciaa1425.
    PubMed     Abstract available


  199. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


    August 2020
  200. KIRWAN PD, Amin-Chowdhury Z, Croxford SE, Sheppard C, et al
    Invasive Pneumococcal Disease in People With Human Immunodeficiency Virus in England, 1999-2017.
    Clin Infect Dis. 2020 Aug 13. pii: 5892189. doi: 10.1093.
    PubMed     Abstract available


  201. GIBNEY KB, MacLachlan J, Coutts R, Higgins N, et al
    Incidence of invasive pneumococcal disease higher among people notified with markers of hepatitis C virus infection: Population-based surveillance in Victoria, Australia 2001-2017.
    Clin Infect Dis. 2020 Aug 4. pii: 5880584. doi: 10.1093/cid/ciaa1110.
    PubMed     Abstract available


    July 2020
  202. DE GRAAF H, Ibrahim M, Hill AR, Gbesemete D, et al
    Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.
    Clin Infect Dis. 2020;71:403-411.
    PubMed     Abstract available


  203. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  204. BEN-SHIMOL S, Dagan R, Givon-Lavi N, Avital D, et al
    Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
    Clin Infect Dis. 2020;71:177-187.
    PubMed     Abstract available


  205. KITT E, Burt S, Price SM, Satchell L, et al
    Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience.
    Clin Infect Dis. 2020 Jun 17. pii: 5858929. doi: 10.1093.
    PubMed     Abstract available


  206. KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
    A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
    Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  207. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2020 May 23. pii: 5911475. doi: 10.1093.
    PubMed    


  208. MAIER HE, Nachbagauer R, Kuan G, Ng S, et al
    Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
    Clin Infect Dis. 2020;70:2290-2297.
    PubMed     Abstract available


  209. MATRAJT L, Halloran ME, Antia R
    Reply to Lindsey, Hoschler, and de Silva.
    Clin Infect Dis. 2020;70:2236-2237.
    PubMed    


    April 2020
  210. NAYAGAM S, Chan P, Zhao K, Sicuri E, et al
    Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Clin Infect Dis. 2020 Apr 7. pii: 5817057. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  211. YIN S, Barker L, Ly KN, Kilmer G, et al
    Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.
    Clin Infect Dis. 2020 Mar 20. pii: 5810334. doi: 10.1093.
    PubMed     Abstract available


  212. GIBNEY KB, Attwood LO, Nicholson S, Tran T, et al
    Emergence of Attenuated Measles Illness Among IgG-positive/IgM-negative Measles Cases: Victoria, Australia, 2008-2017.
    Clin Infect Dis. 2020;70:1060-1067.
    PubMed     Abstract available


    February 2020
  213. MONTO AS, Fukuda K
    Lessons From Influenza Pandemics of the Last 100 Years.
    Clin Infect Dis. 2020;70:951-957.
    PubMed     Abstract available


  214. VINK P
    Reply to Cheng et al and Nellore et al.
    Clin Infect Dis. 2020;70:720-721.
    PubMed    


  215. NELLORE A, Mannon RB, Limaye AP
    Letter to the Editor.
    Clin Infect Dis. 2020;70:719.
    PubMed    


    November 2019
  216. MCKAY SL, Guo A, Pergam SA, Dooling K, et al
    Herpes zoster risk in immunocompromised adults in the United States: A systematic review.
    Clin Infect Dis. 2019 Nov 2. pii: 5611148. doi: 10.1093/cid/ciz1090.
    PubMed     Abstract available


    October 2019
  217. GARCIA GARRIDO HM, Mak AMR, Wit FWNM, Wong GWM, et al
    Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
    Clin Infect Dis. 2019 Oct 21. pii: 5601907. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  218. TSOLENYANU E, Bancroft RE, Sesay AK, Senghore M, et al
    Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lome, Togo.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


    August 2019
  219. KUSHNER T, Chen Z, Tressler S, Kaufman H, et al
    Trends in Hepatitis B Infection and Immunity among Women of Childbearing Age in the United States.
    Clin Infect Dis. 2019 Aug 26. pii: 5554743. doi: 10.1093.
    PubMed     Abstract available


  220. PEAK CM, Stous SS, Healy JM, Hofmeister MG, et al
    Homelessness and Hepatitis A - San Diego County, 2016-2018.
    Clin Infect Dis. 2019 Aug 15. pii: 5550168. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  221. DANANCHE C, Paranhos-Baccala G, Messaoudi M, Sylla M, et al
    Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized With or Without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study.
    Clin Infect Dis. 2019 Jun 25. pii: 5522937. doi: 10.1093.
    PubMed     Abstract available


  222. KING H, Xing J, Dean HD, Holtzman D, et al
    Trends in prevalence of protective levels of hepatitis B surface antibody among adults aged 18-49 years with risk factors for hepatitis B virus infection-United States, 2003-2014.
    Clin Infect Dis. 2019 Jun 20. pii: 5522094. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  223. PIERROTTI LC, Duarte-Neto AN, Song ATW, Ventura CG, et al
    Fatal Yellow Fever in a kidney transplant patient.
    Clin Infect Dis. 2019 May 11. pii: 5488071. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: